Human brain pericytes protect the blood–brain barrier from triple‐negative breast cancer cells while promoting tumor aggressiveness
Journal of Cell Communication and Signaling · 2026-06 · 20 (2)
DOI: 10.1002/ccs3.70070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Communication and Signaling, online erschienen am 03.05.2026. Verfasst von Eloise Happernegg und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Lille CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Pl…. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation pour la Recherche Médicale, Ligue Contre le Cancer, Région Hauts-de-France.
Abstract (Originalsprache)
The majority of breast cancer‐related deaths result from metastatic progression, especially brain metastasis, associated with the poorest prognosis. Patients with triple‐negative breast cancer (TNBC) are particularly prone to developing brain metastases. In this context, the blood–brain barrier (BBB) plays a pivotal role; however, the contribution of brain pericytes in mediating interactions between TNBC cells and the brain endothelial cells (ECs) remains unclear. To investigate the role of pericytes in modulating these interactions, we used a syngeneic human in vitro BBB model, composed of human brain‐like endothelial cells (hBLECs) co‐cultured with human brain pericytes (hBPs). Our findings demonstrate that hBPs secretions significantly reduce TNBC cell adhesion to hBLECs and protect the endothelium from TNBC cell‐induced damage, both under normoxic and hypoxic conditions. Interestingly, we found that hBPs promote TNBC cell migration, invasion, and increase clonogenicity. Together, these findings uncover a dual role of brain pericytes in TNBC brain metastasis: they protect ECs and maintain BBB integrity against TNBC cells while simultaneously promoting tumor aggressiveness. Understanding this balance between protective and pro‐metastatic functions may provide insights for developing novel therapeutic approaches to strengthen BBB defenses and limit brain colonization in TNBC patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Lille CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies Lille France.
- University Artois UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE) Lens France.
- Department of Neurology and Clinical Neuroscience Graduate School of Medicine Yamaguchi University Ube Japan.
- Department of Neurology Neuromuscular Center Yoshimizu Hospital Shimonoseki Japan.
- GdR2082 APPICOM- « Approche Intégrative Pour Une Compréhension Multi-Échelles de La Fonction Des Protéines Membranaires » Paris France.
ORCID-Profile: Eloise Happernegg, Caroline Mysiorek
Förderung
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Région Hauts-de-France
Zitieren
APA
Happernegg, E., Carroué, M., Cicero, J., Dehouck, L., Shimizu, F., Kanda, T., Lagadec, C., Gosselet, F., Le Bourhis, X., Culot, M., Toillon, R. A., & Mysiorek, C. (2026). Human brain pericytes protect the blood–brain barrier from triple‐negative breast cancer cells while promoting tumor aggressiveness. Journal of Cell Communication and Signaling, 20(2). https://doi.org/10.1002/ccs3.70070
Vancouver
Happernegg E, Carroué M, Cicero J, Dehouck L, Shimizu F, Kanda T, et al. Human brain pericytes protect the blood–brain barrier from triple‐negative breast cancer cells while promoting tumor aggressiveness. Journal of Cell Communication and Signaling. 2026;20(2). doi:10.1002/ccs3.70070
BibTeX
@article{Happernegg2026,
author = {Happernegg, Eloise and Carroué, Marine and Cicero, Julien and Dehouck, Lucie and Shimizu, Fumitaka and Kanda, Takashi and Lagadec, Chann and Gosselet, Fabien and Le Bourhis, Xuefen and Culot, Maxime and Toillon, Robert-Alain and Mysiorek, Caroline},
title = {Human brain pericytes protect the blood–brain barrier from triple‐negative breast cancer cells while promoting tumor aggressiveness},
journal = {Journal of Cell Communication and Signaling},
year = {2026},
volume = {20},
number = {2},
doi = {10.1002/ccs3.70070}
}
EUVIMED